top of page

News and press releases

Neurocentria announces Dr. Thomas Sudhof to join the Scientific Advisory Board

Jan 12, 2023

Neurocentria Launches Phase 2b Clinical Trial Testing the Efficacy of MMFS in Stage 3 and 4 Alzheimer’s Disease Patients (NC007b)

Apr 6, 2018

Neurocentria Publishes Article Demonstrating its Candidate Compound MMFS can Improve Brain Age by 9 Years in Older Adults with Mild Cognitive Impairment

Oct 28, 2015

Science Daily: Magnesium Supplement helps boost brain power

Feb 2, 2010

Neurocentria obtains FDA Approval to Conduct Pivotal Phase IIb/III Clinical Trial for Testing Safety and Efficacy of Drug Candidate NRCT-101SR in Adults with ADHD

Feb 15, 2022

Neurocentria Announces Completion and Positive Top-Line Results of MMFS Trial in Adult ADHD

Mar 3, 2018

Neurocentria Presents Results of Phase 2 Clinical Study of MMFS in Elderly with Mild Cognitive Impairment at Alzheimer’s Association International Conference (AAIC) 2015

Jul 13, 2015

WebMD: Magnesium may improve memory

Jan 27, 2010

Neurocentria launches phase 2 trial in stage 2 AD patients focusing on cognition, mood, and sleep (NC010)

Jul 30, 2018

Neurocentria to Present New Data on MMFS in Mild-Moderate Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2017

Jul 13, 2017

Neurocentria Demonstrates that Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice

Sep 13, 2014

MIT News: Magnesium may reverse middle-age memory loss

Dec 1, 2004

bottom of page